About
Impacttherapeutics is a commercial-stage biotechnology company founded in 2009, developing targeted precision oncology therapies based on synthetic lethality to address unmet medical needs in cancer treatment.
Explore Impacttherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.